Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.
Adults receive 400 mg IV or orally once daily in this institutional regimen. The same dose is listed for renal dysfunction and dialysis. This guidance concerns systemic formulations, not ophthalmic moxifloxacin.
Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.
Preserved historical content; not revalidated as current prescribing guidance.
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.
Enter at least two characters. Searches stay on this page and are not saved or sent.
Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.
Open / share selected sourcesThese protocols may disagree and may apply to different settings. This view does not reconcile or endorse a patient-specific regimen.
This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.
Choose one or two sources above or use the source checkboxes below.
These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.
Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Preserved source. Not revalidated as current labeling.
All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.
400 mg orally or IV every 24 hours. Complicated intra-abdominal infection begins with IV treatment; convert to oral when appropriate without adjusting dose. Source durations: bacterial sinusitis 10 days; bronchitis exacerbation 5 days; community-acquired pneumonia 7-14 days; uncomplicated skin infection 7 days; complicated skin infection 7-21 days; complicated intra-abdominal infection 5-14 days.
No adjustment necessary.
No specific guidance was available; the source considers adjustment unlikely.
Open / share this exact local source
Adults receive 400 mg IV or orally once daily in this institutional regimen. The same dose is listed for renal dysfunction and dialysis. This guidance concerns systemic formulations, not ophthalmic moxifloxacin.
RDM30-023-moxifloxacin-1 · Source locator: UCSF - systemic moxifloxacin; renal/dosing sections and stated qualifiers
The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.
Read the full coverage report